Source: Medicines and Medical Devices Safety Authority (NZ) Revision Year: 2019 Publisher: Healthcare Logistics, 58 Richard Pearce Drive, Airport Oaks, AUCKLAND, Telephone (09) 9185100
Cutaneous treatment of Acne vulgaris when comedones, papules and pustules are present.
Epiduo should be applied to the entire acne affected areas once a day in the evening on a clean and dry skin. A thin film of gel should be applied, with the fingertips, avoiding the eyes and lips (see Warnings and Precautions).
If irritation occurs, the patient should be directed to apply non-comedogenic moisturizers, to use the medication less frequently (e.g. every other day), to suspend use temporarily, or to discontinue use altogether.
The duration of treatment should be determined by the doctor on the basis of the clinical condition. Early signs of clinical improvement usually appear after 1 to 4 weeks of treatment.
The safety and effectiveness of Epiduo have not been studied in children below 12 years of age.
Epiduo is for once-daily cutaneous use only. In case of accidental ingestion, appropriate symptomatic measures should be taken.
For information on management of overdose, contact the Poison Information Centre on 0800 746766 (New Zealand).
24 months.
Store below 25°C.
Epiduo in-use stability is at least 6 months after first opening.
2 g, 5 g, 15 g, 30 g, 45 g, 60 g and 90g HDPE tubes closed with a white polypropylene screw-cap.
15 g, 30 g, 45 g and 60 g PP bottles with pump, closed with a PP cap.
Not all pack sizes may be marketed.
Not applicable.
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
